Invenomic Capital Management LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001769456

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidDiversifiedHigh Turnover how tags are computed

Q1 2025 · 171 positions · Total reported value $1.98B · Top-10 concentration 22.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 66.9% · 35 new · 31 cut · 35 exited

Active Share (vs S&P 500): 99.0% · vs QQQ: 99.1% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +2.7% · vs SPY +0.6% · Prev Value $1.67B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +8.2% · vs SPY +6.1% · Latest Value $2.02B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2025 13F filing, Invenomic Capital Management LP disclosed 171 equity positions with a combined reported value of $1.98B. The filing implies a diversified portfolio: its ten largest positions account for 22.2% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.

The largest disclosed positions as of Q1 2025 were VTRS ($56.06M), AKAM ($52.14M), GPN ($49.35M). By sector, the heaviest allocations are Consumer Discretionary 25.9%, Technology 16.4%. Versus the prior quarter, allocation shifted toward Industrials (+7.9pp), Materials (+4.6pp) and away from Utilities (-3.6pp), Consumer Staples (-4.8pp).

Versus the prior quarter, Invenomic Capital Management LP opened 35 new positions, trimmed 31 and fully exited 35, a turnover rate of 66.9% of positions. The portfolio's overlap with the prior quarter was 59% of names.

The largest new positions opened in Q1 2025 were WBD ($34.92M), PVH ($20.08M), FIS ($19.37M).

Of the 35 positions fully exited versus the prior quarter, the largest were QQQ ($191.71M), SPY ($117.22M), TAP ($37.38M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

  • WBD WARNER BROS DISCOVERY INC · $34.92M
  • PVH PVH CORPORATION · $20.08M
  • FIS FIDELITY NATL INFORMATION SV · $19.37M
  • IOVA IOVANCE BIOTHERAPEUTICS INC · $18.28M
  • GOLD GOLD COM INC · $14.65M
  • MATV MATIV HOLDINGS INC · $13.84M
  • FHI FEDERATED HERMES INC · $11.70M
  • CAL CALERES INC · $11.60M

Fully Exited (vs previous quarter)

  • QQQ INVESCO QQQ TR · prev qtr: $191.71M
  • SPY STATE STR SPDR S&P 500 ETF T · prev qtr: $117.22M
  • TAP MOLSON COORS BEVERAGE CO · prev qtr: $37.38M
  • T AT&T INC · prev qtr: $29.96M
  • SSNC SS&C TECH HLDGS · prev qtr: $28.03M
  • PLD PROLOGIS INC. · prev qtr: $21.98M
  • SOLV SOLVENTUM CORP · prev qtr: $21.18M
  • UGI UGI CORP NEW · prev qtr: $17.36M

Insider Transactions (Form 4)

Latest Invenomic Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Invenomic Capital Management LP is an SEC-registered 13F filer based in Boston, MA, United States. As of Q3 2026 it reported 116 US equity positions with a combined value of $2.02B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: BOSTON, MA, United States
  • SEC registration: 801-110459 (status: Approved), registered 2017-04-20
  • Regulatory AUM (Form ADV): $3.39B as of 2026-03-31
  • Client mix (by RAUM): registered investment companies 60%, pension and profit-sharing plans 40%
  • Manages 2 private funds, of which 2 hedge funds

Portfolio Structure

  • 116 positions · $2.02B reported value (Q3 2026)
  • Top 10 holdings = 29.4% of reported value
  • Largest position: UHS (UNIVERSAL HLTH SVCS INC) at 3.9%
  • Average position size: $17.43M

Sector Tilt

  • Consumer Discretionary 28.5%
  • Information Technology 26.1%
  • Industrials 14.9%
  • (classified holdings cover 98% of value)

Quarterly Activity

  • Q3 2026: 35 new, 45 added, 31 reduced, 35 exited
  • 5 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 16.4%
Industrials 13.9%
Health Care 11.6%
Energy 6.8%
Materials 4.6%
Other 16.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 6.44M $56.06M 2.83%
2.83%
Add
2 647.66K $52.14M 2.63%
2.63%
Add
3 503.97K $49.35M 2.49%
2.49%
Reduce
4 344.73K $47.64M 2.41%
2.41%
Add
5 3.59M $42.58M 2.15%
2.15%
Add
6 357.46K $40.29M 2.04%
2.04%
Add
7 1.58M $38.45M 1.94%
1.94%
Add
8 2.26M $38.05M 1.92%
1.92%
Add
9 802.20K $37.90M 1.91%
1.91%
Add
10 2.48M $37.00M 1.87%
1.87%
Reduce
11 1.15M $35.81M 1.81%
1.81%
Add
12 3.25M $34.92M 1.76%
1.76%
New
13 3.76M $33.59M 1.70%
1.70%
Add
14 8.48M $33.33M 1.68%
1.68%
Add
15 1.86M $30.32M 1.53%
1.53%
Add
16 534.26K $29.73M 1.50%
1.50%
Reduce
17 431.49K $28.15M 1.42%
1.42%
Add
18 639.60K $27.37M 1.38%
1.38%
Reduce
19 2.47M $24.14M 1.22%
1.22%
Add
20 566.19K $23.67M 1.20%
1.20%
Add
21 600.89K $23.56M 1.19%
1.19%
Add
22 510.40K $23.15M 1.17%
1.17%
Add
23 279.80K $22.31M 1.13%
1.13%
Add
24 1.72M $21.66M 1.09%
1.09%
Add
25 1.16M $20.63M 1.04%
1.04%
Add
26 310.57K $20.08M 1.01%
1.01%
New
27 684.01K $19.43M 0.98%
0.98%
Add
28 259.36K $19.37M 0.98%
0.98%
New
29 907.39K $18.41M 0.93%
0.93%
Add
30 5.49M $18.28M 0.92%
0.92%
New
31 1.23M $18.10M 0.91%
0.91%
Add
32 121.72K $17.73M 0.90%
0.90%
Add
33 1.98M $17.28M 0.87%
0.87%
Add
34 230.26K $17.25M 0.87%
0.87%
Add
35 449.78K $17.19M 0.87%
0.87%
Add
36 1.89M $17.06M 0.86%
0.86%
Add
37 224.69K $16.58M 0.84%
0.84%
Reduce
38 266.55K $16.56M 0.84%
0.84%
Reduce
39 885.02K $16.49M 0.83%
0.83%
Add
40 1.99M $15.76M 0.80%
0.80%
Add
41 393.00K $15.68M 0.79%
0.79%
Add
42 76.70K $15.65M 0.79%
0.79%
Add
43 169.18K $15.63M 0.79%
0.79%
Add
44 88.06K $15.53M 0.78%
0.78%
Add
45 84.67K $15.13M 0.76%
0.76%
Reduce
46 570.71K $14.92M 0.75%
0.75%
Add
47 650.59K $14.65M 0.74%
0.74%
New
48 995.86K $14.39M 0.73%
0.73%
Add
49 1.51M $14.39M 0.73%
0.73%
Add
50 118.76K $14.19M 0.72%
0.72%
Add

FAQ

What did Invenomic Capital Management LP buy in 2025-Q1?

In its 2025-Q1 13F filing, Invenomic Capital Management LP reported 171 equity positions worth $1.98B in aggregate; its largest disclosed positions were VTRS ($56.06M), AKAM ($52.14M), GPN ($49.35M).

How large is Invenomic Capital Management LP's portfolio?

Invenomic Capital Management LP reported $1.98B of long equity holdings across 171 positions as of 2025-Q1. Top-10 holdings account for 22.2% of reported value.

What is Invenomic Capital Management LP's investment style?

HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/invenomic-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →